Literature DB >> 9294976

DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol.

C L Duvauchelle1, S M Fleming, C Kornetsky.   

Abstract

The role of dopamine neurotransmission in opioid reward was investigated using a rate-independent measure for determining brain stimulation reward (BSR) thresholds. Intra-accumbens infusions of the mu- and delta-specific peptides, D-Ala2, N-Me-Phe4, Gly-ol5-Enkephalin and D-Pen2, D-Pen5-Enkephalin caused significant lowering of BSR thresholds. The dopamine D1/D2 antagonist, cis-flupenthixol, blocked these effects at a dose that did not significantly alter thresholds when given alone. These data suggest both mu- and delta-opioid potentiation of BSR is dopamine dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294976     DOI: 10.1016/s0028-3908(97)00075-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.

Authors:  Gail Pereira Do Carmo; Nancy K Mello; Kenner C Rice; John E Folk; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2006-07-05       Impact factor: 4.432

Review 2.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

Review 3.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

4.  The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.

Authors:  Gail Pereira Do Carmo; John E Folk; Kenner C Rice; Elena Chartoff; William A Carlezon; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2008-12-24       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.